eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
14.72
-0.28 (-1.84%)
At close: Dec 5, 2025, 4:00 PM EST
14.85
+0.13 (0.85%)
After-hours: Dec 5, 2025, 4:00 PM EST
eXoZymes Employees
eXoZymes had 31 employees as of December 31, 2024. The number of employees increased by 2 or 6.90% compared to the previous year.
Employees
31
Change (1Y)
2
Growth (1Y)
6.90%
Revenue / Employee
n/a
Profits / Employee
-$269,022
Market Cap
123.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31 | 2 | 6.90% |
| Dec 31, 2023 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EXOZ News
- 22 days ago - eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today - Accesswire
- 22 days ago - eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff - Accesswire
- 25 days ago - eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST - Accesswire
- 5 weeks ago - CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference - Accesswire
- 5 weeks ago - CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference - Accesswire
- 6 weeks ago - CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference - Accesswire
- 2 months ago - Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees - Accesswire
- 4 months ago - eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today - Accesswire